Skip to main content
. 2016 Nov 24;8(1):1007–1022. doi: 10.18632/oncotarget.13537

Table 1. Tumor incidence in limiting dilution assay.

Tumor incidence/injection
Cells Injected 1,000 100 10 Estimated cancer stem cell frequency with confidence intervals (95%)
4T1-DMSO 10/10 10/10 7/10 1 in 9 (4-18)
4T1-Benztropine mesylate 8/10 7/10 5/10 1 in 218 (100-479)***

4T1-luc2 spheres pretreated with benztropine mesylate or DMSO were dissociated into single-cell suspensions and injected into the mammary fat pads of mice in limiting dilution (10; 100; 1,000). Tumor formation was observed for four weeks following inoculation. BCSC frequency was calculated using ELDA.